IRIS
MUSTI, Anna Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.747
NA - Nord America 1.199
AS - Asia 126
AF - Africa 35
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 3.114
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.167
RU - Federazione Russa 1.039
UA - Ucraina 261
DE - Germania 165
AT - Austria 126
SE - Svezia 101
TR - Turchia 41
CN - Cina 40
SN - Senegal 35
CA - Canada 32
IN - India 32
FI - Finlandia 16
IT - Italia 14
GB - Regno Unito 8
NL - Olanda 6
RO - Romania 6
JP - Giappone 4
HK - Hong Kong 3
AU - Australia 2
EU - Europa 2
PL - Polonia 2
SG - Singapore 2
AL - Albania 1
BD - Bangladesh 1
BO - Bolivia 1
BR - Brasile 1
EC - Ecuador 1
ES - Italia 1
HR - Croazia 1
IR - Iran 1
KH - Cambogia 1
KZ - Kazakistan 1
Totale 3.114
Salva come PNG Salva come JPEG
Città #
Moscow 1.039
Chandler 298
Jacksonville 167
San Mateo 110
Vienna 88
Dearborn 86
Izmir 39
Ashburn 38
Dakar 35
Roxbury 35
Lawrence 34
Brooklyn 27
Ottawa 25
New York 24
Des Moines 22
Flensburg 21
Helsinki 16
Wilmington 15
Beijing 11
Shanghai 10
Cambridge 9
Grafing 8
Inglewood 8
Ogden 8
Rende 7
Ann Arbor 6
Bangalore 6
Pune 6
Toronto 6
Bremen 5
Los Angeles 5
Seattle 5
Mömbris 4
Tokyo 4
Falls Church 3
Atlanta 2
Boardman 2
Changsha 2
Flensburg-mürwik 2
Hong Kong 2
Houston 2
Jinan 2
Lanzhou 2
Leawood 2
Nanchang 2
Naples 2
San Francisco 2
Woodbridge 2
Almaty 1
Ardabil 1
Berlin 1
Canberra 1
Chengdu 1
Chennai 1
Dhaka 1
Falkenstein 1
Fuzhou 1
Gießen 1
Groningen 1
Guangzhou 1
Hanover 1
Hefei 1
Kent 1
Kilburn 1
London 1
Melbourne 1
Monmouth Junction 1
Mumbai 1
Nanjing 1
Nanning 1
Norwalk 1
Pentone 1
Phnom Penh 1
Quito 1
Sucre 1
Taizhou 1
Tappahannock 1
Tirana 1
Warsaw 1
Washington 1
Wroclaw 1
Wuxi 1
Zhengzhou 1
Totale 2.291
Salva come PNG Salva come JPEG
Nome #
c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells 1.099
17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30 103
17 beta -Estradiol, Genistein and 4-Hydroxytamoxifen induce proliferative effects in thyroid cancer cells via G protein couplet-receptor GPR30. 96
The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells 85
GPER Mediates Non-Genomic Effects of Estrogen 82
17beta- estradiol, genistein and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein coupled – receptor GPR30. 80
Crosstalk between Notch, HIF-1α and GPER in breast cancer EMT 80
ERK docking sites mediate the differential capacity of c-Jun and JunD to respond to ERK-signaling 77
Channelrhodopsin-1: a light-gated proton channel in green algae 74
Menin promotes S-phase checkpoint and increases the ratio of homology-directed DNA repair 73
G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells 70
Differential phosphorylation of c-Jun and JunD in response to the epidermal growth factor is determined by the structure of MAPK targeting sequences 67
V-RAS PKC dedifferentiate thyroid cells by downregulating nuclear cAMP dependent protein kinase A 66
A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells 66
Distinct configurations of ERK docking sites mediate the differential capacity of c-Jun and JunD to sense the duration of ERK-signalling 64
Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation 62
Differential regulation of c-Jun and JunD by ubiquitin-dependent protein degradation 62
The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells 58
GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs) 57
Differential Phosphorylation of c-Jun and JunD in Response to EGF is Determined by the Structure of MAPK targeting sequences 56
Menin uncouples Elk-1 and junD phosphorylation from MAP kinase activation 56
c-Jun is essential for the induction of Il-1β gene expression in in vitro 53
The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17-beta estradiol and hydroxitamoxifen in endometrial cancer cells 51
The v-ki-ras oncogene alters cAMP nuclear signaling by regulating the location and the expression of cAMP-dependent protein kinase IIB 49
Analysis of JunD N-terminal phosphorylation in the menin-JunD complex 49
Ubiquitin in signal transduction and cell transformation 49
The DEXD/H-box RNA helicase RHII/Gu is a co-factor for c-Jun-activated transcription 48
Thyroid transcription factor 1 phosphorylation is not required for protein kinase A-dependent transcription of the thyroglobulin promoter 47
The G protein-coupled receptor GPR30 mediates the prolifertaive effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells. 44
Negative charged threonine 95 of c-Jun is essential for c-Jun N-terminal kinase-dependent phosphorylation of threonine 91/93 and stress-induced c-Jun biological activity 41
Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis 41
Reduced ubiquitin-depebndent degradetion of c-jun after phosphorylation by MAP kinases 39
Multiple members of the mitogen-activated protein kinase family are necessary for PED/PEA-15 anti-apoptotic function 35
Multisite phosphorylation of c-Jun at threonine 91/93/95 triggers the onset of c-Jun pro-apoptotic activity in cerebellar granule neurons 34
The Multifaceted Output of c-Jun Biological Activity: Focus at the Junction of CD8 T Cell Activation and Exhaustion 28
Totale 3.141
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.759
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201939 0 0 0 0 0 0 0 0 0 0 39 0
2019/2020341 36 34 0 35 18 90 28 39 6 3 37 15
2020/2021341 46 0 34 35 1 39 0 45 63 34 13 31
2021/2022458 1 51 2 50 48 10 2 116 5 7 58 108
2022/2023627 67 100 35 103 63 71 0 60 70 12 13 33
2023/20241.272 55 20 31 7 25 198 376 340 28 158 34 0
Totale 3.141